VYGR
Voyager Therapeutics
$3.09
−$0.01 (−0.32%)Jul 27, 2026
Key metrics
The numbers that frame VYGR today
- Market cap
- $186.70M
- P/E (TTM)
- -1.6
- EV / FCF
- -1.3
- Gross margin
- 100%
- EV / Sales
- 4.8
- ROIC
- -51.9%
- Div yield
- 0%
- Debt / equity
- 0.2
- 52wk Low
- $2.88
- 52wk High
- $5.55
Growth
Revenue and earnings trend for VYGR
RevenueNet income
See the full growth breakdown
Revenue and earnings trends, margins and the multi-year trajectory - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inCash flow & returns
Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture
Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.
Create a free accountFree foreverNo card required
Already a member? Log inInsider trading
Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade
See who is buying and selling, how much, and when - updated as new filings land.
Create a free accountFree foreverNo card required
Already a member? Log inFrequently asked questions
Plain-English answers about VYGR
Is Voyager Therapeutics a good buy?
No. Voyager Therapeutics has weak quality and weak momentum. Both signals point to a weaker setup. Growth looks poor. That could put pressure on the long-term business case. We think Voyager Therapeutics is selling at a very high price.
What is the market capitalization of VYGR?
Voyager Therapeutics's market capitalization is $186.70M.
What is the P/E ratio for VYGR stock?
Voyager Therapeutics's current P/E ratio is -1.6.
What is the 52-week high for VYGR stock?
The 52-week high for Voyager Therapeutics is $5.55. The current close of $3.09 is 44.3% below that high.
What is the 52-week low for VYGR stock?
The 52-week low for Voyager Therapeutics is $2.88. The current close of $3.09 is 7.1% above that low.
Does VYGR stock pay dividends?
Voyager Therapeutics does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for VYGR?
Voyager Therapeutics's Debt / Equity ratio is 0.2.